An innovative gynecological HDR brachytherapy applicator system for treatment delivery and real-time verification.


Journal

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
ISSN: 1724-191X
Titre abrégé: Phys Med
Pays: Italy
ID NLM: 9302888

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 03 12 2018
revised: 27 02 2019
accepted: 01 03 2019
pubmed: 11 3 2019
medline: 16 4 2019
entrez: 11 3 2019
Statut: ppublish

Résumé

The multichannel vaginal cylinder (MVC) applicator employed for gynecological high dose rate (HDR) brachytherapy increases dose delivery complexity, and thus makes the treatment more prone to errors. A quality assurance (QA) procedure tracking the source throughout dose delivery can detect dwell position and time errors in the multiple channels of the applicator. A new MVC system with integrated real time in vivo treatment delivery QA has been developed based on diodes embedded on the outer surface of the MVC. It has been pre-calibrated and verified using a non-clinical treatment plan with consecutive test positions and dwell times within each catheter, followed by the delivery of ten clinical plans of adjuvant vaginal cuff brachytherapy following hysterectomy for endometrial cancer. The non-clinical verification showed overall mean dwell position and time discrepancies between the nominal and measured treatment of -0.2 ± 0.5 mm and -0.1 ± 0.1 s (k = 1), respectively. The clinical plans showed mean positional discrepancies of 0.2 ± 0.4 and 0.0 ± 0.8 mm, for the central and peripheral catheters, respectively, and mean dwell time discrepancies of -0.1 ± 0.2 and -0.0 ± 0.1 s for central and peripheral catheters, respectively. The innovative prototype of the MVC system has shown the ability to track the source with sub-mm and sub-second accuracy, and demonstrated potential for its incorporation into the clinical routine.

Identifiants

pubmed: 30852055
pii: S1120-1797(19)30044-4
doi: 10.1016/j.ejmp.2019.03.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

151-157

Informations de copyright

Copyright © 2019 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.

Auteurs

Anna Romanyukha (A)

Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia.

Mauro Carrara (M)

Medical Physics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. Electronic address: mauro.carrara@istitutotumori.mi.it.

Davide Mazzeo (D)

Department of Physics, Università degli Studi di Milano, Milan, Italy.

Chiara Tenconi (C)

Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.

Tebarak Al-Salmani (T)

Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia.

Joel Poder (J)

St George Cancer Care Center, Kogarah, NSW, Australia.

Dean Cutajar (D)

Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia.

Iolanda Fuduli (I)

Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia.

Marco Petasecca (M)

Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia.

Joseph Bucci (J)

St George Cancer Care Center, Kogarah, NSW, Australia.

Annamaria Cerrotta (A)

Radiation Oncology 2 Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

Brigida Pappalardi (B)

Radiation Oncology 2 Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

Federica Piccolo (F)

Radiation Oncology 2 Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

Emanuele Pignoli (E)

Medical Physics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

Anatoly Rosenfeld (A)

Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH